Preferential Inhibition of Hepatocellular Carcinoma by the Flavonoid Baicalein Through Blocking MEK-ERK Signaling

International Journal of Oncology - Greece
doi 10.3892/ijo.2012.1510
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Baicalein Inhibits Melanogenesis Through Activation of the ERK Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2010English

Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2017English

STYK1 Promotes Epithelial-Mesenchymal Transition and Tumor Metastasis in Human Hepatocellular Carcinoma Through MEK/ERK and PI3K/AKT Signaling

Scientific Reports
Multidisciplinary
2016English

Norcantharidin Induces Growth Inhibition and Apoptosis of Glioma Cells by Blocking the Raf/Mek/Erk Pathway

World Journal of Surgical Oncology
SurgeryOncology
2014English

Sorafenib Increases Efficacy of Vorinostat Against Human Hepatocellular Carcinoma Through Transduction Inhibition of Vorinostat-Induced ERK/NF-κB Signaling

International Journal of Oncology
Cancer ResearchOncology
2014English

Glypican-3 Promotes Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells Through ERK Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2015English

Long Non‑coding RNA Igf2as Controls Hepatocellular Carcinoma Progression Through the ERK/MAPK Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2017English

Cinobufacini Inhibits Epithelial-Mesenchymal Transition of Human Hepatocellular Carcinoma Cells Through C-Met/Erk Signaling Pathway

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2018English

Inhibition of Mitogen-Activated Protein Kinase Cascade by Baicalein, a Flavonoid of Natural Origin

Folia Pharmacologica Japonica
Pharmacology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy